Navigation Links
Global $7.52 Billion Next Generation Sequencing Market Assessment & Forecast: 2017-2021 - Opportunities in Reagents and Consumables Segment - Research and Markets
Date:3/17/2017

DUBLIN, Mar. 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Next Generation Sequencing Market Assessment & Forecast: 2017 - 2021" report to their offering.

The Global Next Generation Sequencing Market Was Valued at US$ 3,509.6 Million in 2016 And is Expected to Reach US$ 7,527.0 Million By 2021 Growing at a CAGR of 16.02%.

The market has witnessed series of acquisitions and strategic agreements in the recent past and become more competitive. It is also anticipated that the market would consolidate, remain dominated by the North America region. However, rapid growth is anticipated in Asia Pacific region due to increased adoption of the technology in varied fields. In 2016, China announced the opening of China National GeneBank (CNGB). The bank consists of biorepository, bioinformatics data center and living biobank, and a digitalization platform and synthesis and editing platform. Similar gene banks in Japan, South Korea, India and others are contributing immensely to genetic research in agriculture. Chinese FDA granted Class I status for Vela Diagnostics' Sentosa SX101 instrument for clinical use. In 2015, KEW Group Inc. and Denka Co., Ltd. announced collaborative agreement for evaluation of KEW's CancerPlex NGS Testing in Japanese cancer patients.

Government investment in genome sequencing projects and widespread integration of NGS technology with other research programs are driving the NGS market. Increasing efforts by regulatory agencies in keeping pace with rapid technology developments and proactive approach in approval of NGS based tests in disease diagnosis has encouraged companies and investment firms to consider NGS technology as one of the most lucrative options.

Next generation sequencing (NGS) technology market is constantly evolving due to continuous technology upgrades. At least five companies are currently developing novel NGS technology that is anticipated to commercialize during the forecast period. Although currently the market is dominated by Illumina, various other companies are investing in development of novel methods for efficient and cost effective sequencing. Genapsys is currently developing Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology, a portable sequencer targeted for research and diagnostic laboratory purposes.

The company opened early access registration in 2014, yet commercial launch has not been announced officially. Agilent Technologies invested US$ 80 million in LaserGen for development and commercialization of the proprietary lightning terminators technology. Although Nabsys had closed operations in 2015 after 10 years of struggle in development of its next generation sequencing technology, the company was re-launched as Nabsys 2.0 in 2016. The company also received US$ 42 million in funding from a Chinese company Zixin Pharma. Majority of the sequencing technologies in pipeline are nanopore based.

Key players mentioned in the report include Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore, Pacific Biosciences, Qiagen N.V., Roche Sequencing, Stratos Genomics, GnuBio and others.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Précis

Chapter 3 Market Dynamics

Chapter 4 Next Generation Sequencing - Global Market Assessment by Key Players, Forecast: 2017 to 2021

Chapter 5 Next Generation Sequencing Services - Global Market Assessment by Applications, Forecast:  2017 to 2021

Chapter 6 Next Generation Sequencing Instruments, Reagents and Consumables - Global Market Assessment by End-Users, Forecast: 2017 to 2021

Chapter 7 Next Generation Sequencing - Global Market Assessment by Geography, Forecast: 2017 to 2021

Chapter 8 Key Player Analysis: Global Next Generation Sequencing Market, 2016

Chapter 9 Epilogue

Companies Mentioned

  • GnuBio.
  • Illumina Inc.
  • Oxford Nanopore
  • Pacific Biosciences
  • Qiagen N.V.
  • Roche Sequencing
  • Stratos Genomics
  • Thermo Fisher Scientific Inc.

For more information about this report visit http://www.researchandmarkets.com/research/j7mxgj/global_next

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-752-billion-next-generation-sequencing-market-assessment--forecast-2017-2021---opportunities-in-reagents-and-consumables-segment---research-and-markets-300425400.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Global $1.47 Billion Biostimulants Market to 2022 - Research and Markets
2. Mylan to Present at Barclays Global Healthcare Conference
3. Global Stem Cell Technologies and Applications Market 2017-2027
4. Global Bioplastics Market - Trends and Forecasts (2016-2021) - Global Production Capacity Will Rise to 7.6 Million Metric Tonnes by 2019 - Research and Markets
5. Global Bioinsecticides Market to Reach $774 Million by 2020 - Growth Primarily Attributed to Advancements in Biopesticides Industry - Research and Markets
6. Global Genetic disorders Partnering 2010-2017: Deal trends, players and financials
7. Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology
8. Global Licensing Partnering Report: Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016 - Research and Markets
9. AMRI to Present at Barclays Global Healthcare Conference
10. ITL Limited agiert jetzt als ITL Health Group, um Bereiche unter globaler Marke zu vereinen
11. ACEA Biosciences Hires Roger Luo as Vice President of Global Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , June ... Cornell University, a leader in dairy research, today announced ... designed to help reduce the chances that the global ... onset of this dairy project, Cornell University has become ... Sequencing the Food Supply Chain, a food safety initiative ...
(Date:5/6/2017)... 2017 RAM Group , Singaporean ... breakthrough in biometric authentication based on a ... to perform biometric authentication. These new sensors are based ... by Ram Group and its partners. This sensor will ... chains and security. Ram Group is a next ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
Breaking Biology News(10 mins):